Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Licensing opportunity from BTG: topically active 5-LO inhibitor for psoriasis

Oct. 21, 1998

Negotiations between Altana and Hyal for licensing Solarase terminated

Oct. 19, 1998

Access signs agreement for amlexanox distribution in four additional markets

Oct. 19, 1998

Successful completion of human safety trials reported for VIMRx wound-healing agent

Oct. 14, 1998

Access signs more agreements for distribution of amlexanox

Oct. 14, 1998

More data reported for ADCON-P; FDA okays pivotal trial

Oct. 14, 1998

Demegen's Peptidyl MIM compound D4B effectively treats infected wounds

Oct. 13, 1998

Xoma completes phase II enrollment in psoriasis study

Oct. 13, 1998

Bristol-Myers Squibb and Unilever enter collaborative agreement for hair loss research

Oct. 9, 1998

Nonpeptide BK antagonist effective in guinea pig models of allergy

Oct. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...